Quantum BioPharma Ltd.

QNTM | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.73

+$0.12 (+3.32%)

Sep 22, 2026, 1:17 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $23.1M

Enterprise Value $14.33M

Beta 0.45

Average Volume 299.41K

Shares Outstanding (Diluted) 6.65M

Shares Change YoY 120.17%

Institutional Ownership 5.66%

Exchange NASDAQ

ISIN CA74764Y2050

Price Performance

Price Change 1M 5.3%

Price Change 3M -6.2%

Price Change 6M -17.0%

Price Change YTD -48.5%

Price Change 1Y -80.5%

Price Change 3Y -95.6%

Price Change 5Y -96.4%

1M CAGR (ann.) 4.6%

1Y CAGR (ann.) -81.9%

5Y CAGR (ann.) -49.3%

All-Time CAGR -50.0%

Valuation

PE Ratio -0.64

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS 0.90

PB Ratio 2.91

P/FCF Ratio -4.26

P/Adj. FCF Ratio -2.85

P/OCF Ratio -4.46

EV/Sales N/A

EV/EBIT -0.59

EV/EBITDA -0.61

EV/FCF -2.65

Earnings Yield -156.5%

FCF Yield -23.4%

Adj. FCF Yield -35.1%

Financial Health

Net Cash $8.77M

Total Debt $962.16K

Cash & Short-Term Investments $9.73M

Total Assets $14.37M

Current Ratio 1.20

Quick Ratio 1.19

Debt / Equity Ratio 0.12

Debt / EBITDA -0.04

Debt / FCF -0.18

OCF / Debt -5.63

Interest Coverage -5.00

Altman Z-Score -24.67

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -49.8%

Returns

Return on Assets -173.1%

Return on Equity -413.1%

Return on Invested Capital -27.1%

Return on Capital Employed -31.4%

Return on Tangible Assets -247.0%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -21.5%

EPS CAGR 3Y 25.0%

EPS CAGR 5Y 37.8%

EPS CAGR 10Y 16.0%

FCF CAGR 3Y -1.6%

FCF CAGR 5Y 35.8%

FCF CAGR 10Y -4.5%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 5, 2026

EPS Estimate (next Q) -$0.50

EPS Growth Est (next Q) -60.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-5.42M

Free Cash Flow $-5.42M

Adj. Free Cash Flow $-8.11M

FCF Per Share -$0.81

OCF Per Share -$0.81

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-250.78K

Operating Income $-1.91M

EBITDA $-23.66M

Net Income $-24.89M

EPS (Diluted) -$5.65

Revenue / Employee N/A

Profit / Employee $-1.46M

Employees 17